Related Experiment Video

Updated: Jun 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Cardiomyopathy in children

S C Chen1

  • 1Division of Pediatric Cardiology, Saint Louis University School of Medicine, 1465 South Grand Boulevard, 63104, St. Louis, MO, USA, chenm5@slu.edu.

Current Treatment Options in Cardiovascular Medicine
|September 18, 2010
PubMed

Insights

Pediatric cardiomyopathy, including dilated (DCM) and hypertrophic (HCM) forms, requires cause-targeted treatment and medical management to improve heart failure symptoms and survival rates in children.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Diseases
  • Genetics and Rare Diseases

Background:

  • Cardiomyopathy in children is a rare condition with high mortality, often leading to heart failure.
  • Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) are the most prevalent types in pediatric populations.
  • Arrhythmogenic right ventricular dysplasia (ARVD) is exceptionally rare in children.

Purpose of the Study:

  • To review the current understanding and management strategies for various pediatric cardiomyopathies.
  • To highlight the importance of etiological diagnosis and targeted treatment approaches.
  • To discuss therapeutic options ranging from medical management to cardiac transplantation.

Main Methods:

  • Literature review of pediatric cardiomyopathy epidemiology, diagnosis, and treatment.
  • Synthesis of current clinical guidelines and therapeutic recommendations.
  • Analysis of treatment efficacy for different cardiomyopathy subtypes in children.

Main Results:

  • Treatment strategies vary based on cardiomyopathy type (DCM, HCM, RCM) and underlying cause.
  • Medical therapies including inotropes, diuretics, ACE inhibitors, and beta-blockers are crucial for symptom management.
  • Immunosuppression, anticoagulation, antiarrhythmic therapy, and cardiac transplant are indicated in specific pediatric cases.

Conclusions:

  • Effective management of pediatric cardiomyopathy necessitates a cause-specific approach.
  • Optimized medical therapy and timely interventions, including transplantation, can improve outcomes.
  • Further research into pediatric cardiomyopathy treatment, especially beta-blocker use in DCM, is warranted.
Abstract

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...